These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 22964231)

  • 1. Manipulating the mediator: modulation of the alternative complement pathway C3 convertase in health, disease and therapy.
    Ricklin D
    Immunobiology; 2012 Nov; 217(11):1057-66. PubMed ID: 22964231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
    Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.
    Rooijakkers SH; Wu J; Ruyken M; van Domselaar R; Planken KL; Tzekou A; Ricklin D; Lambris JD; Janssen BJ; van Strijp JA; Gros P
    Nat Immunol; 2009 Jul; 10(7):721-7. PubMed ID: 19503103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A humanized antibody that regulates the alternative pathway convertase: potential for therapy of renal disease associated with nephritic factors.
    Paixão-Cavalcante D; Torreira E; Lindorfer MA; Rodriguez de Cordoba S; Morgan BP; Taylor RP; Llorca O; Harris CL
    J Immunol; 2014 May; 192(10):4844-51. PubMed ID: 24729617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons from functional and structural analyses of disease-associated genetic variants in the complement alternative pathway.
    Rodríguez de Córdoba S; Harris CL; Morgan BP; Llorca O
    Biochim Biophys Acta; 2011 Jan; 1812(1):12-22. PubMed ID: 20837143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase.
    Bettoni S; Bresin E; Remuzzi G; Noris M; Donadelli R
    J Biol Chem; 2016 Apr; 291(15):8214-30. PubMed ID: 26903516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.
    Pangburn MK; Müller-Eberhard HJ
    J Exp Med; 1980 Oct; 152(4):1102-14. PubMed ID: 6903192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase.
    Torreira E; Tortajada A; Montes T; Rodríguez de Córdoba S; Llorca O
    Proc Natl Acad Sci U S A; 2009 Jan; 106(3):882-7. PubMed ID: 19136636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional analysis of a C3b-specific antibody that selectively inhibits the alternative pathway of complement.
    Katschke KJ; Stawicki S; Yin J; Steffek M; Xi H; Sturgeon L; Hass PE; Loyet KM; Deforge L; Wu Y; van Lookeren Campagne M; Wiesmann C
    J Biol Chem; 2009 Apr; 284(16):10473-9. PubMed ID: 19196712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Characterization of Alternative and Classical Pathway C3/C5 Convertase Activity and Inhibition Using Purified Models.
    Zwarthoff SA; Berends ETM; Mol S; Ruyken M; Aerts PC; Józsi M; de Haas CJC; Rooijakkers SHM; Gorham RD
    Front Immunol; 2018; 9():1691. PubMed ID: 30083158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cleavage of the third component of human complement (C3) by its small cleavage fragment, C3a: inhibition occurs with the classical-pathway, but not the alternative-pathway, C3 convertase.
    Strunk RC; Webster RO
    Mol Immunol; 1985 Jan; 22(1):37-43. PubMed ID: 3871899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A structurally dynamic N-terminal helix is a key functional determinant in staphylococcal complement inhibitor (SCIN) proteins.
    Garcia BL; Summers BJ; Ramyar KX; Tzekou A; Lin Z; Ricklin D; Lambris JD; Laity JH; Geisbrecht BV
    J Biol Chem; 2013 Jan; 288(4):2870-81. PubMed ID: 23233676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
    Medicus RG; Götze O; Müller-Eberhard HJ
    J Exp Med; 1976 Oct; 144(4):1076-93. PubMed ID: 978134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of C3 and its ligands in complement activation.
    Volanakis JE
    Curr Top Microbiol Immunol; 1990; 153():1-21. PubMed ID: 2404692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement inhibition at the level of C3 or C5: mechanistic reasons for ongoing terminal pathway activity.
    Mannes M; Dopler A; Zolk O; Lang SJ; Halbgebauer R; Höchsmann B; Skerra A; Braun CK; Huber-Lang M; Schrezenmeier H; Schmidt CQ
    Blood; 2021 Jan; 137(4):443-455. PubMed ID: 33507296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family.
    Ricklin D; Tzekou A; Garcia BL; Hammel M; McWhorter WJ; Sfyroera G; Wu YQ; Holers VM; Herbert AP; Barlow PN; Geisbrecht BV; Lambris JD
    J Immunol; 2009 Aug; 183(4):2565-74. PubMed ID: 19625656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3 adsorbed to a polymer surface can form an initiating alternative pathway convertase.
    Andersson J; Ekdahl KN; Larsson R; Nilsson UR; Nilsson B
    J Immunol; 2002 Jun; 168(11):5786-91. PubMed ID: 12023380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb).
    Bexborn F; Andersson PO; Chen H; Nilsson B; Ekdahl KN
    Mol Immunol; 2008 Apr; 45(8):2370-9. PubMed ID: 18096230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN.
    Donadelli R; Pulieri P; Piras R; Iatropoulos P; Valoti E; Benigni A; Remuzzi G; Noris M
    Front Immunol; 2018; 9():2329. PubMed ID: 30487789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of peptidic inhibitors of the alternative complement pathway based on Staphylococcus aureus SCIN proteins.
    Summers BJ; Garcia BL; Woehl JL; Ramyar KX; Yao X; Geisbrecht BV
    Mol Immunol; 2015 Oct; 67(2 Pt B):193-205. PubMed ID: 26052070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.